Wegovy is a brand name for the medication liraglutide, which is a type of glucagon-like peptide-1 (GLP-1) receptor agonist. It was approved by the US Food and Drug Administration (FDA) in June 2021 for chronic weight management in adults with obesity or who are overweight and have at least one weight-related health condition.
HOW DOES WEGOVY WORK?
Wegovy works by mimicking the effects of a natural hormone in the body called GLP-1. This hormone is released by the gut in response to food intake and helps to regulate blood sugar levels and reduce appetite. By activating GLP-1 receptors in the brain, Wegovy can help to reduce hunger and increase feelings of fullness, which can lead to a reduction in calorie intake and weight loss.
BENEFITS OF WEGOVY
Wegovy has been shown to be effective in aiding weight loss in clinical trials. In a study involving over 2,000 participants with obesity or who were overweight with at least one weight-related health condition, those who took Wegovy lost an average of 15% of their body weight over 68 weeks, compared to those who took a placebo and lost an average of 2.4% of their body weight.
In addition to aiding weight loss, Wegovy has also been shown to have potential benefits for blood sugar control and cardiovascular health. In clinical trials, it was found to improve glycemic control in patients with type 2 diabetes and to reduce the risk of major adverse cardiovascular events in patients with established cardiovascular disease.
POTENTIAL SIDE EFFECTS OF WEGOVY
As with any medication, Wegovy can have potential side effects. Some common side effects of Wegovy include nausea, diarrhea, vomiting, and constipation. The majority of the time, these side effects are minor and become better with time.
In rare cases, more serious side effects can occur, such as pancreatitis or gallbladder disease. It is important to talk to a healthcare provider about any concerns regarding potential side effects before starting Wegovy.
HOW LONG DO MOST PEOPLE NEED TO STAY ON WEGOVY?
The length of time a person needs to stay on Wegovy can vary depending on individual weight loss goals and healthcare provider recommendations. In clinical trials, participants took Wegovy for up to 68 weeks. It is important to work with a healthcare provider to determine the appropriate length of treatment.
IS WEGOVY RIGHT FOR YOU?
Wegovy may be a suitable treatment option for adults with obesity or who are overweight and have at least one weight-related health condition. However, it is important to note that Wegovy is not a magic solution for weight loss and should be used in combination with other weight loss strategies, such as a healthy diet and regular exercise.
Wegovy is not recommended for use in people with a personal or family history of medullary thyroid carcinoma (MTC) or in people with a rare genetic condition called multiple endocrine neoplasia syndrome type 2 (MEN 2). It is important to discuss any personal or family medical history with a healthcare provider before starting Wegovy.
In addition, Wegovy is not recommended for use during pregnancy or breastfeeding. Women who become pregnant while taking Wegovy should discontinue use and speak to a healthcare provider.
WHAT TO EXPECT?
In conclusion, Wegovy can be a suitable treatment option for adults with obesity or who are overweight and have at least one weight-related health condition. However, it is important to discuss potential side effects and individual suitability with a healthcare provider before starting Wegovy. It should also be used in combination with other weight loss strategies, such as a healthy diet and regular exercise.
Specialty Care Clinics offers medical guidance on the use of the newly approved anti-obesity drug, Wegovy. It promotes weight loss and improves diabetes and cardiovascular health. Physicians’ guidance and a healthy lifestyle, including a balanced diet and exercise, are crucial for successful weight management.